DTC genetic testing
International Consensus Statement Says Microbiome-Based Diagnostic Tests Not Ready for Prime Time
Researchers laid out a set of ethical, organizational, and technical guidelines for the development, commercial use, and clinical implementation of microbiome tests.
NowPatient Inks Pharmacogenomics Testing Deals with Aura Genetics, Zotz Klimas
Through the collaborations, UK-based NowPatient will expand its services to pharmacogenomic testing.
The Tennessee-based firm is combining molecular and protein testing technologies that it brought under one roof in a pair of deals last summer.
Direct-to-consumer microbiome tests often go beyond what the research can support, but the large databases being generated by some companies are supporting diagnostic development.
EDP Biotech, New Day Diagnostics to Merge
The new entity will keep the New Day Diagnostics name as the companies unite under a unified leadership structure.